Search by Drug Name or NDC
NDC 73336-0075-30 GEMTESA 75 mg/1 Details
GEMTESA 75 mg/1
GEMTESA is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sumitomo Pharma America, Inc.. The primary component is VIBEGRON.
MedlinePlus Drug Summary
Vibegron is used to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination) in adults. Vibegron is in a class of medications called beta-3 adrenergic agonists. It works by relaxing the bladder muscles to increase bladder capacity.
Related Packages: 73336-0075-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Vibegron
Product Information
| NDC | 73336-0075 |
|---|---|
| Product ID | 73336-075_dff76a29-8827-4ba4-8ee8-27921744748a |
| Associated GPIs | 54200080000320 |
| GCN Sequence Number | 081787 |
| GCN Sequence Number Description | vibegron TABLET 75 MG ORAL |
| HIC3 | R1V |
| HIC3 Description | OVERACTIVE BLADDER AGENTS, BETA-3 ADRENERGIC RECEP |
| GCN | 49009 |
| HICL Sequence Number | 047040 |
| HICL Sequence Number Description | VIBEGRON |
| Brand/Generic | Brand |
| Proprietary Name | GEMTESA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | vibegron |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/1 |
| Substance Name | VIBEGRON |
| Labeler Name | Sumitomo Pharma America, Inc. |
| Pharmaceutical Class | Adrenergic beta3-Agonists [MoA], beta3-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA213006 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 73336-0075-30 (73336007530)
| NDC Package Code | 73336-075-30 |
|---|---|
| Billing NDC | 73336007530 |
| Package | 30 TABLET, FILM COATED in 1 BOTTLE (73336-075-30) |
| Marketing Start Date | 2020-12-29 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 15.5189 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | GEMTESA 75 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis